Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP537236.RAgOlVUWYSijnXW8w2Pa7MNfV6Oh6gkJYLjLa_ifqV13E130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP537236.RAgOlVUWYSijnXW8w2Pa7MNfV6Oh6gkJYLjLa_ifqV13E130_assertion type Assertion NP537236.RAgOlVUWYSijnXW8w2Pa7MNfV6Oh6gkJYLjLa_ifqV13E130_head.
- NP537236.RAgOlVUWYSijnXW8w2Pa7MNfV6Oh6gkJYLjLa_ifqV13E130_assertion description "[Because solid tumors expressing ECGF-1 could also be lysed by the CTL, ECGF-1 is an interesting target for immunotherapy of both hematologic and solid tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP537236.RAgOlVUWYSijnXW8w2Pa7MNfV6Oh6gkJYLjLa_ifqV13E130_provenance.
- NP537236.RAgOlVUWYSijnXW8w2Pa7MNfV6Oh6gkJYLjLa_ifqV13E130_assertion evidence source_evidence_literature NP537236.RAgOlVUWYSijnXW8w2Pa7MNfV6Oh6gkJYLjLa_ifqV13E130_provenance.
- NP537236.RAgOlVUWYSijnXW8w2Pa7MNfV6Oh6gkJYLjLa_ifqV13E130_assertion SIO_000772 16497972 NP537236.RAgOlVUWYSijnXW8w2Pa7MNfV6Oh6gkJYLjLa_ifqV13E130_provenance.
- NP537236.RAgOlVUWYSijnXW8w2Pa7MNfV6Oh6gkJYLjLa_ifqV13E130_assertion wasDerivedFrom befree-2016 NP537236.RAgOlVUWYSijnXW8w2Pa7MNfV6Oh6gkJYLjLa_ifqV13E130_provenance.
- NP537236.RAgOlVUWYSijnXW8w2Pa7MNfV6Oh6gkJYLjLa_ifqV13E130_assertion wasGeneratedBy ECO_0000203 NP537236.RAgOlVUWYSijnXW8w2Pa7MNfV6Oh6gkJYLjLa_ifqV13E130_provenance.